 | | |  | |
|---|
 | Adrenal gland |
| |
| Arm |
| |
| Bladder |
| |
 | Bones |
| |
| 4.1 | Bisphosphonate (zoledronic acid)-induced osteonecrosis of the jaw.
Reference Type: Treatment for Specific Mets
Reference Source: Clinical-Reviews: Pubmed.gov
| Nov 10, 2009 | |
| 4.2 | Bisphosphonates For At Least 6 Months Reduces Risk of Some Skeletal Morbidity Among Patients with Bone Metastases
Reference Type: Treatment for Specific Mets
Reference Source: Clinical-Reviews: Doctor's Guide
| Sept 3, 2003 | |
| 4.3 | New study results show ability of Zometa to delay onset of skeletal-related events, progression of skeletal disease
Reference Type: Treatment for Specific Mets
Reference Source: Clinical-Trial: Pharmexec
| Sept 2, 2003 | |
| 4.4 | Zoledronic Acid Reduces Skeletal Complications of Solid Tumors
Reference Type: Treatment for Specific Mets
Reference Source: Clinical-Trial: Medscape
| Aug 22, 2003 | |
| 4.5 | Some cancer patients now have a less painful alternative to surgery
Reference Type: Treatment for Specific Mets
Reference Source: Media-Article: The Sacramento Bee
| July 29, 2003 | |
| 4.6 | Bondronat for treatment of Metastatic Bone Disease Clears Important Regulatory Hurdle in Europe
Reference Type: Treatment for Specific Mets
Reference Source: Media-Article: primezone
| July 28, 2003 | |
| 4.7 | ASCO: Bone Turnover Marker Helps Identify Risk of Skeletal Events in Patients with Metastatic Bone Disease
Reference Type: Treatment for Specific Mets
Reference Source: Unknown: DG News
| June 5, 2003 | |
| 4.8 | ASCO: Zoledronic Acid Reduces Skeletal Events in a Variety of Solid Tumour Cancers
Reference Type: Treatment for Specific Mets
Reference Source: Clinical-Trial: DG News
| June 3, 2003 | |
| 4.9 | Single-fraction radiotherapy the treatment of choice for painful bone metastases
Reference Type: Treatment for Specific Mets
Reference Source: Clinical-Trial: OncoLink Cancer News
| Feb 10, 2003 | |
| 4.10 | Zoledronic Acid Similar To Pamidronate For Treatment Of Osteolytic Bone Lesions In Multiple Myeloma
Reference Type: Treatment for Specific Mets
Reference Source: Clinical-Reviews: Doctor's Guide
| Dec 9, 2002 | |
| 4.11 | Radiofrequency Ablation Eases Pain Caused by Bone Metastases
Reference Type: Treatment for Specific Mets
Reference Source: Media-Article: Doctor's Guide
| Dec 5, 2002 | |
| 4.12 | Procedure Offers Relief of Intractable Bone Pain
Reference Type: Treatment for Specific Mets
Reference Source: Media-Article: cancerpage.com
| Oct 31, 2002 | |
| 4.13 | Early results promising for radium-223 against bone metastases
Reference Type: Treatment for Specific Mets
Reference Source: Media-Article: OncoLink
| July 1, 2002 | |
| 4.14 | Tyrosine kinase inhibitors show promise as treatment for bone metastases
Reference Type: Treatment for Specific Mets
Reference Source: Media-Article: OncoLink
| Apr 9, 2002 | |
| 4.15 | FDA Approves Zometa (Zoledronic Acid) for Treatment of Cancer-Related Bone Complications
Reference Type: Treatment for Specific Mets
Reference Source: Unknown: Doctor's Guide
| Feb 25, 2002 | |
| 4.16 | FDA clears Novartis' Zometa for bone metastases
Reference Type: Treatment for Specific Mets
Reference Source: Media-Article: OncoLink Cancer News
| Feb 22, 2002 | |
| 4.17 | Radio Frequency Ablation Relieves Pain of Spinal Tumours
Reference Type: Treatment for Specific Mets
Reference Source: Media-Article: Doctor's Guide
| Feb 19, 2002 | |
| 4.18 | Novartis cancer drug gets US priority review
Reference Type: Treatment for Specific Mets
Reference Source: Media-Article: OncoLink Cancer News
| Oct 24, 2001 | |
| 4.19 | Rhenium-188 hedp to treat painful bone metastases.
Reference Type: Treatment for Specific Mets
Reference Source: Clinical-Trial: PubMed
| Oct 1, 2001 | |
| 4.20 | Drugmaker sees expanding potential for cancer drug after FDA approval
Reference Type: Treatment for Specific Mets
Reference Source: Media-Article: CNN.com
| Aug 21, 2001 | |
| 4.21 | FDA Approves Zometa (Zoledronic Acid) For Hypercalcemia of Malignancy
Reference Type: Treatment for Specific Mets
Reference Source: Media-Article: Doctor's Guide
| Aug 21, 2001 | |
| 4.22 | Initial Phase III Data Show Novartis' Zometa Effective Against Cancer-Related Bone Complications
Reference Type: Treatment for Specific Mets
Reference Source: Clinical-Trial: MEDSCAPE's Urology MedPulse(R)
| May 3, 2001 | |
| 4.23 | Evaluation of bone metastases from renal cell carcinoma
Reference Type: Metastatic Overview Information
Reference Source: Clinical Trial Abstract: Cancernet
| Mar 1, 2001 | |
| 4.24 | Beating Bone Cancer
Reference Type: Treatment for Specific Mets
Reference Source: Media-Article: Ivanhoe Newswire
| Jan 6, 2001 | |
| 4.25 | Palliative surgery can benefit patients with renal cell carcinoma metastatic to bone
Reference Type: Treatment for Specific Mets
Reference Source: Media-Article: OncoLink
| Nov 13, 2000 | |
| 4.26 | METASTATIC RENAL CELL CARCINOMA OF BONE: INDICATIONS AND TECHNIQUE OF SURGICAL INTERVENTION
Reference Type: Treatment for Specific Mets
Reference Source: Clinical-Reviews: The Journal of Urology
| Nov 1, 2000 | |